Retrospective Study
Copyright ©The Author(s) 2025.
World J Gastrointest Surg. Feb 27, 2025; 17(2): 99531
Published online Feb 27, 2025. doi: 10.4240/wjgs.v17.i2.99531
Table 1 Inter-group comparison of basic data, n (%)
Groups
Survival group (n = 47)
Death group (n = 40)
Statistical values
P value
Sex4.3150.092
Male35 (74.47)31 (77.50)
Female12 (25.53)9 (22.50)
Age (years old)49.31 ± 10.2950.32 ± 11.235.3270.153
Body mass index (kg/m2)22.94 ± 2.3422.97 ± 2.504.1420.325
Disease course (years)9.21 ± 3.209.25 ± 3.325.4240.619
Type of primary disease4.5270.153
Viral hepatitis32 (68.09)28 (70.00)
Alcoholic hepatitis10 (21.28)8 (20.00)
Drug-induced hepatitis4 (8.51)3 (7.50)
Others1 (2.13)1 (2.50)
Table 2 Inter-group comparison of alpha-fetoprotein, prothrombin activity, and prealbumin levels among acute-on-chronic liver failure patients with different survival outcomes, mean ± SD
Groups
Survival group (n = 47)
Death group (n = 40)
Statistical values
P value
AFP (ng/mL)120.99 ± 11.8177.65 ± 25.1410.539< 0.001
PTA (μg/L)34.81 ± 8.1125.84 ± 4.566.207< 0.001
PA (mg/L)85.08 ± 24.3050.27 ± 22.186.930< 0.001
Table 3 Correlations of alpha-fetoprotein, prothrombin activity, and prealbumin with different survival outcomes
GroupsSurvival outcomes (survival)
r
P value
AFP (ng/mL)0.753< 0.001
PTA (μg/L)0.559< 0.001
PA (mg/L)0.601< 0.001
Table 4 Diagnostic value of alpha-fetoprotein + prothrombin activity + prealbumin detection for prognosis of acute-on-chronic liver failure patients
Indicators
Sensitivity (%)
Specificity (%)
Youden index
Cut-off
AUC
95%CI
AFP (ng/mL)80.00100.000.80099.0800.9070.839-0.976
PTA (μg/L)74.5087.500.62030.7950.8490.766-0.931
PA (mg/L)70.2095.500.65278.2350.8530.773-0.933
Joint detection95.7095.500.907-0.9890.974-1.000